Ovid Therapeutics
(NASDAQ) OVID
Ovid Therapeutics Financials at a Glance
Market Cap
$466.60M
Revenue (TTM)
$7.12M
Net Income (TTM)
-$24.17M
EPS (TTM)
-$0.24
P/E Ratio
-10.28
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$2.51
Volume
10
Open
$2.31
Price
$2.51
Volume
10
Open
$2.31
Previous Close
$2.50
Daily Range
$2.29 - $2.53
52-Week Range
$0.30 - $3.11
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$2.51
Volume
10
Open
$2.31
Previous Close
$2.50
Daily Range
$2.29 - $2.53
52-Week Range
$0.30 - $3.11
Estimated Earnings Date
Aug 12, 2026
OVID News
3 Top Biotech Stocks to Buy Now
OVID: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ovid Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
23
CEO
Margaret Alexander
Website
www.ovidrx.comHeadquarters
New York City, NY 10036, US
OVID Financials
Key Financial Metrics (TTM)
Gross Margin
99.51%
Operating Margin
-670.25%
Net Income Margin
-339.33%
Return on Equity
-22.51%
Return on Capital
-29.46%
Return on Assets
-10.71%
Earnings Yield
-9.73%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$466.60M
Shares Outstanding
186.64M
Volume
10
Avg. Volume
2.53M
Financials (TTM)
Gross Profit
$7.09M
Operating Income
-$47.74M
EBITDA
-$24.00M
Operating Cash Flow
-$41.95M
Capital Expenditure
$0.00
Free Cash Flow
-$41.95M
Cash & ST Invst.
$155.52M
Total Debt
$1.46M
Ovid Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
-$35.00K
-126.9%
Gross Margin
0.00%
N/A
Market Cap
$466.60M
N/A
Market Cap/Employee
$20.29M
N/A
Employees
23
N/A
Net Income
-$16.99M
-66.0%
EBITDA
-$16.95M
-68.0%
Quarterly Fundamentals
Total Cash
$155.52M
+261.7%
Total Debt
$1.46M
-89.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$1.46M
+7.3%
Return on Assets
-10.71%
N/A
Return on Invested Capital
-22.74%
N/A
Free Cash Flow
-$13.90M
-35.2%
Operating Cash Flow
-$13.90M
-35.2%